Vera Therapeutics, Inc. · NASDAQ:VERA
Fordyce Marshall sold 18,500 Vera Therapeutics, Inc. shares (Form 4/A)
Traded May 12, 2026 · Filed Aug 12, 2026
On May 12, 2026, Fordyce Marshall (Director, PRESIDENT AND CEO) sold 18,500 Vera Therapeutics, Inc. shares at an average US$36.74 for US$680K under a trading plan, leaving 235,244 shares. Filed Aug 12, 2026 (Form 4/A).
- Sold
- 18,500 shares
- Price
- US$36.74 average (US$36.64 to US$37.09)
- Value
- US$680K
- Holding after
- 235,244 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 12, 2026 | Class A Common Stock | Option exercise | 18,500 | US$2.90 | 253,744 | Direct |
| May 12, 2026 | Class A Common Stock | Sale | 14,219 | US$36.64 | 239,525 | Direct |
| May 12, 2026 | Class A Common Stock | Sale | 4,281 | US$37.09 | 235,244 | Direct |
Source
Related
- Vera Therapeutics, Inc.
- Fordyce Marshall
- Vera Therapeutics, Inc. shareholders
- Form 4 · Fordyce Marshall · Sep 17, 2026
- Form 4 · Fordyce Marshall · Sep 4, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4/A · Fordyce Marshall · Aug 12, 2026
- Form 4 · Fordyce Marshall · Jun 24, 2026
- Form 4 · Young Joseph R · Sep 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Boman Nancy Lee · Aug 5, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 30, 2026